WallStreetZenWallStreetZen

NASDAQ: RYTM
Rhythm Pharmaceuticals Inc Stock Ownership - Who owns Rhythm Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Rhythm Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
David P. MeekerCEO;Pres2026-09-1430,746$102.35
$3.15MSell
David P. MeekerCEO;Pres2026-09-142,300$105.19
$241.94kSell
David P. MeekerCEO;Pres2026-09-141,817$104.55
$189.97kSell
David P. MeekerCEO;Pres2026-09-148,698$103.43
$899.63kSell
David P. MeekerCEO;Pres2026-09-1450,000$6.05
$302.50kBuy
David P. MeekerCEO;Pres2026-09-146,439$101.75
$655.14kSell
Hunter C. SmithCFO2026-08-3157,187$25.79
$1.47MBuy
Hunter C. SmithCFO2026-08-3128,188$106.20
$2.99MSell
Hunter C. SmithCFO2026-08-3111,514$105.37
$1.21MSell
Hunter C. SmithCFO2026-08-3123,072$104.59
$2.41MSell

1 of 9

RYTM insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RYTM insiders and whales buy or sell their stock.

RYTM Shareholders

What type of owners hold Rhythm Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ra Capital Management LP6.33%4,360,860$427.41MInsider
Orbimed Advisors LLC3.99%2,750,079$269.54MInsider
Todd Foley1.32%909,258$89.12MInsider
Keith Michael Gottesdiener0.81%558,250$54.71MInsider
David P. Meeker0.35%239,258$23.45MInsider
Hunter C. Smith0.17%114,024$11.18MInsider
Third Rock Ventures LP0.14%99,105$9.71MInsider
Yann Mazabraud0.08%55,655$5.45MInsider
Nithya Desikan0.06%43,602$4.27MInsider
Der Ploeg Leonardus Ht Van0.06%42,339$4.15MInsider

1 of 3

RYTM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RYTM0.11%13.54%Net SellingNet Selling
CGON0.11%16.34%Net BuyingNet Buying
BLTE0.02%0.31%Net SellingNet Selling
ORKA0.05%99.95%Net SellingNet Selling
MIRM0.11%81.26%Net BuyingNet Selling
View Top Biotech Stocks

Rhythm Pharmaceuticals Stock Ownership FAQ

Who owns Rhythm Pharmaceuticals?

Rhythm Pharmaceuticals (NASDAQ: RYTM) is owned by 0.11% institutional shareholders, 13.54% Rhythm Pharmaceuticals insiders, and 86.35% retail investors. Ra Capital Management LP is the largest individual Rhythm Pharmaceuticals shareholder, owning 4.36M shares representing 6.33% of the company. Ra Capital Management LP's Rhythm Pharmaceuticals shares are currently valued at $431.81M.

If you're new to stock investing, here's how to buy Rhythm Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.